Prof Peter Hotez says Baylor College of Medicine licensed its low cost protein Covid vaccine technology to multiple manufacturers, with early partners producing and delivering 100 million Corbevax doses for India.
So to clarify, Baylor Coll Med licensed our low-cost protein Covid vaccine technology to four entities
The first two produced and delivered 100 million vaccine doses as Corbevax for India
BioE (India), BioFarma (Indonesia), Incepta (Bangladesh), ImmunityBio (U.S./S. Africa)
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare